A CONTRACEPTIVE pill for men is on the horizon after early human trials found it to be safe. Up until now, the primary male birth control options have been condoms and vasectomy.  A ...

(OTCQB:EVFM) to become the sourcing partner for the contraceptive vaginal gel, PHEXXI®. The hormone-free product, controlled by women, has achieved annual revenues exceeding $19 million from ...

The gel, which men rub on their upper bodies daily, delivers synthetic progestin to block the testes from producing normal levels of sperm. Jef Akst was managing editor of The Scientist, where she ...

(NASDAQ:WINT), a biotechnology firm, has announced a License and Supply Agreement with Evofem Biosciences, Inc. (OTCQB:EVFM) to become the sourcing partner for the contraceptive vaginal gel, PHEXXI®.

Evofem Biosciences (EVFM) announced that it has entered into a License and Supply Agreement with Windtree Therapeutics (WINT), under which ...

Windtree Therapeutics (WINT) announces that it has entered into a License and Supply Agreement to become the sourcing partner for Evofem ...

A new gel that men rub into their shoulders every day is the latest in a series of developments that are not only changing the landscape of male contraceptive options, but also highlighting the ...